Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6986916 | 0.98 | GAA (0.54) | GAAALDH1A1GFERLMNAL3MBTL1 | |
| SCHEMBL13594698 | 0.88 | ALDH1A1 (0.56) | GAAALDH1A1GFERLMNAL3MBTL1 | |
| SCHEMBL18159276 | 0.88 | GAA (0.49) | GAAALDH1A1GFERLMNAL3MBTL1 | |
| SCHEMBL7247237 | 0.86 | ALDH1A1 (0.69) | GAAALDH1A1GFERLMNAL3MBTL1 | |
| SCHEMBL908271 | 0.86 | ABL1 (0.59) | GAAALDH1A1LMNAL3MBTL1HTT | |
| Hydrochloric Acid SCHEMBL6983661 | 0.84 | ALDH1A1 (0.67) | GAAALDH1A1GFERLMNAL3MBTL1 | |
| SCHEMBL12191688 | 0.84 | L3MBTL1 (0.50) | GAAALDH1A1L3MBTL1DRD2ABL1 | |
| Hydrochloric Acid SCHEMBL6986396 | 0.84 | CYP4F2 (0.54) | GAAALDH1A1LMNAL3MBTL1HTT | |
| SCHEMBL118588 | 0.84 | ALDH1A1 (0.53) | GAAALDH1A1GFERLMNAL3MBTL1 | |
| SCHEMBL31287243 | 0.84 | ALDH1A1 (0.53) | GAAALDH1A1GFERLMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335673-B2 | 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2008-02-26 | — | — | US | disclosed |
| US-20040072878-A1 | 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| EP-1325903-A1 | 2,3-DIPHENYLPROPIONIC ACID DERIVATIVES OR THEIR SALTS, MEDICINES OR CELL ADHESION INHIBITORS CONTAINING THE SAME, AND THEIR USAGE | Kaken Pharmaceutical Co., Ltd. (JP) | 2003-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040072878-A1 | 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage | VCAM1, ICAM1, PTK2 | GAA 1941/4885ALDH1A1 194/4885GFER 3709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.